Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board
April 16, 2025
Adial Pharmaceuticals Announces Completion of Last Patient, Last Visit in its ONWARD(TM) Phase 3 Trial of AD04 for the Treatment of Patients with Alcohol Use Disorder
February 24, 2022
Related Post
-
-
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company
April 16, 2025
-
INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom(TM) Manufacturing for Commercial Readiness
April 14, 2025
-
Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
April 14, 2025